Serum S100 protein: A potential marker for cerebral events during cardiopulmonary bypass

被引:213
作者
Westaby, S
Johnsson, P
Parry, AJ
Blomqvist, S
Solem, JO
Alling, C
Pillai, R
Taggart, DP
Grebenik, C
Stahl, E
机构
[1] Oxford Heart Centre, Oxford Radcliffe Hospital, Oxford
关键词
D O I
10.1016/0003-4975(95)00904-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. There is no simple method to determine the incidence or severity of brain injury after a cardiac operation. A serum marker equivalent to cardiac enzymes is required. S100 protein leaks from the cerebrospinal fluid to blood after cerebral injury. We sought to determine the pattern of release after extracorporeal circulation (ECC). Methods. Thirty-four patients without neurologic problems underwent coronary bypass using ECC. Four had carotid stenoses. Nine others underwent coronary bypass without ECC. Serum S100 levels were measured before, during, and after the operation. Results. S100 was not detected before sternotomy. Postoperative levels of S100 were related to duration of perfusion (r = 0.89, p < 0.001). Patients who did not have ECC had undetectable or fractionally raised levels except in 1 who suffered a stroke. No patient in whom ECC was used suffered an event, but those with carotid stenoses had greater S100 levels. Conclusions. S100 protein leaks into blood during ECC and may reflect both cerebral injury and increased permeability of the blood brain barrier. S100 is a promising marker for cerebral injury in cardiac surgery if elevated levels can be linked with clinical outcome.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 30 条
  • [21] PSYCHIATRIC COMPLICATIONS OF OPEN-HEART SURGERY
    KORNFELD, DS
    ZIMBERG, S
    MALM, JR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (06) : 287 - &
  • [22] TOTAL CREATINE-KINASE ACTIVITY IN CEREBROSPINAL-FLUID AS AN INDICATOR OF BRAIN-DAMAGE DURING OPEN-HEART SURGERY
    LUNDAR, T
    STOKKE, O
    [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 17 (02): : 157 - 161
  • [23] MURKIN JM, 1987, ANESTH ANALG, V66, P825
  • [24] S-100 PROTEIN AND NEURON-SPECIFIC ENOLASE IN CEREBROSPINAL-FLUID AND SERUM - MARKERS OF CELL-DAMAGE IN HUMAN CENTRAL-NERVOUS-SYSTEM
    PERSSON, L
    HARDEMARK, HG
    GUSTAFSSON, J
    RUNDSTROM, G
    MENDELHARTVIG, I
    ESSCHER, T
    PAHLMAN, S
    [J]. STROKE, 1987, 18 (05) : 911 - 918
  • [25] CENTRAL-NERVOUS-SYSTEM DAMAGE DURING CARDIAC-SURGERY ASSESSED BY 3-DIFFERENT BIOCHEMICAL MARKERS IN CEREBROSPINAL-FLUID
    SELLMAN, M
    IVERT, T
    RONQUIST, G
    CAESARINI, K
    PERSSON, L
    SEMB, BKH
    [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 26 (01): : 39 - 45
  • [26] SHAW PJ, 1986, Q J MED, V58, P59
  • [27] EARLY NEUROLOGICAL COMPLICATIONS OF CORONARY-ARTERY BYPASS-SURGERY
    SHAW, PJ
    BATES, D
    CARTLIDGE, NEF
    HEAVISIDE, D
    JULIAN, DG
    SHAW, DA
    [J]. BRITISH MEDICAL JOURNAL, 1985, 291 (6506) : 1384 - 1387
  • [28] ASSESSMENT OF DAMAGE TO THE CENTRAL NERVOUS-SYSTEM BY DETERMINATION OF S-100 PROTEIN IN THE CEREBROSPINAL-FLUID
    SINDIC, CJM
    CHALON, MP
    CAMBIASO, CL
    LATERRE, EC
    MASSON, PL
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1982, 45 (12) : 1130 - 1135
  • [29] SLOGOFF S, 1982, ANESTH ANALG, V61, P903
  • [30] USUI A, 1989, CLIN CHEM, V35, P1942